Vice President, Consulting, Certara
Dr. Felix Boakye-Agyeman is Vice President of Pharmacometrics within the Integrated Drug Development (IDD) group at Certara, a global leader in model-informed drug development. Certara partners with more than 2,300 organizations worldwide and has contributed over 99% of all new drug approvals in the past decade.
At Certara, Dr. Boakye-Agyeman leads a multidisciplinary team of scientists who integrate quantitative modeling and clinical pharmacology, and to optimize drug development across therapeutic areas. His work has directly supported the development and approval of multiple therapies, particularly in oncology, immunology, and pediatric indications.
With a background spanning medicine, clinical pharmacology, and quantitative sciences, Dr. Boakye-Agyeman is recognized for advancing model-informed strategies for special and vulnerable populations, ensuring that data-driven innovation translates into safer and more effective therapies.
Prior to joining Certara, he held leadership roles at Synteract, where he oversaw pharmacometric consulting for adult and pediatric programs, and at the Duke Clinical Research Institute (DCRI), supporting early-phase and pediatric trials through the NIH-funded Pediatric Trials Network. His contributions have informed pediatric dosing strategies and labeling updates by major regulatory agencies, including the FDA, EMA, PMDA, NMPA, and Health Canada.
Beyond his role at Certara, Dr. Boakye-Agyeman serves on the Board of Africa Partners Medical (APM), where for over 15 years he has contributed to health system strengthening, medical training, and quality improvement initiatives across Ghana and West Africa.
Functional Expertise
- 群体 PK
- Exposure Response Analysis
- PK/PD 分析
- Non-compartmental analysis
- Concentration QTc analysis
- 临床药理学
实践领域
- 肿瘤学
- Autoimmune
- Infectious diseases
- Antibody drug conjugates (ADC)
- Special Populations (Pediatrics, Maternal Health)
Sr. Director, Pharmacometrics
Huub is a senior pharmacometrician with an in-depth knowledge of pharma R&D, with 20+ years of pharmaceutical industry / consulting experience. He has a broad regulatory experience reflected by contributions to multiple new drug applications across therapeutic areas. He has proficient modeling skills in population PK, PKPD and exposure-response analysis. Huub has demonstrated ability to successfully lead pharmacometric project teams covering the full chain from scoping, pricing, setting up M&S analysis plans, execution of analysis and authoring regulatory quality reports.
Functional Expertise
- 临床药理学
- DMPK
- 药物开发战略
- Non-compartmental analysis
- PK/PD 分析
- 群体 PK
实践领域
- Antibody drug conjugates (ADC)
- 中枢神经系统（CNS）
- 肿瘤学
- Orphan diseases
- 儿科
- Psychiatric
